Clinical trial
PREMIUM Migraine Trial
NCT00355056 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00355056 |
|---|---|
| Title | PREMIUM Migraine Trial |
| Official title | Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management. |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Migraine Headaches, Patent Foramen Ovale |
| Intervention type | Device, Other |
| Interventions | Sham Procedure, AMPLATZER PFO Occluder |
| Enrollment | 230 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Jul 21, 2006 |
| Last update posted | Jul 30, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 10–99 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: